Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001179110-08-006431
Filing Date
2008-03-21
Accepted
2008-03-21 08:39:20
Documents
1
Period of Report
2008-03-13

Document Format Files

Seq Description Document Type Size
1 FORM 3 - edgar.html 3  
1 FORM 3 - edgar.xml 3 2213
  Complete submission text file 0001179110-08-006431.txt   4184
Mailing Address 7000 SHORELINE COURT SUITE 370 SOUTH SAN FRANCISCO CA 94080
Business Address 7000 SHORELINE COURT SUITE 370 SOUTH SAN FRANCISCO CA 94080 6505886404
Hana Biosciences Inc (Issuer) CIK: 0001140028 (see all company filings)

EIN.: 841588441 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O LIGAND PHARMACEUTICALS INC., 10275 SCIENCE CENTER DR. SAN DIEGO CA 92121
Business Address 8585507577
MAIER PAUL V (Reporting) CIK: 0001182615 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-32626 | Film No.: 08704163